| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma
|
Ghione, Paola
|
|
|
24 |
5 |
p. e191-e195.e6
|
artikel
|
| 2 |
An Open-Label Phase I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma
|
Alodhaibi, Ibrahim
|
|
|
24 |
5 |
p. 298-304
|
artikel
|
| 3 |
A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia
|
Kantarjian, Hagop M.
|
|
|
24 |
5 |
p. 285-297
|
artikel
|
| 4 |
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
|
Pasvolsky, Oren
|
|
|
24 |
5 |
p. e196-e204
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
24 |
5 |
p. A6-A7
|
artikel
|
| 6 |
Geographic and Racial Disparities in Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma
|
Shahzad, Moazzam
|
|
|
24 |
5 |
p. 316-322
|
artikel
|
| 7 |
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study
|
Jaccard, Arnaud
|
|
|
24 |
5 |
p. e205-e216
|
artikel
|
| 8 |
Optimizing the CAR T-Cell Therapy Experience in Multiple Myeloma: Clinical Pearls From an Expert Roundtable
|
Ailawadhi, Sikander
|
|
|
24 |
5 |
p. e217-e225
|
artikel
|
| 9 |
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
|
Garg, Mahek
|
|
|
24 |
5 |
p. e181-e190
|
artikel
|
| 10 |
Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study
|
Hillyer, Alexandra
|
|
|
24 |
5 |
p. 305-315
|
artikel
|
| 11 |
SOHO State of the Art Updates and Next Questions: Update on the Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
|
Haddad, Fadi G.
|
|
|
24 |
5 |
p. 271-276
|
artikel
|
| 12 |
SOHO State of the Art Updates and Next Questions: Will CAR-T Replace ASCT in NDMM
|
Jurgens, Eric
|
|
|
24 |
5 |
p. 277-284
|
artikel
|
| 13 |
Table of Contents
|
|
|
|
24 |
5 |
p. A9-A10
|
artikel
|
| 14 |
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan
|
Malagola, Michele
|
|
|
24 |
5 |
p. 323-331
|
artikel
|
Tijdschrift beschrijving